Q2 EPS Estimates for Ocular Therapeutix Cut by HC Wainwright
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) – Investment analysts at HC Wainwright reduced their Q2 2025 EPS estimates for shares of Ocular Therapeutix in a note issued to investors on Tuesday, May 6th. HC Wainwright analyst Y. Chen now anticipates that the biopharmaceutical company will earn ($0.37) per share for the quarter, down from […]
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) – Investment analysts at HC Wainwright reduced their Q2 2025 EPS estimates for shares of Ocular Therapeutix in a note issued to investors on Tuesday, May 6th. HC Wainwright analyst Y. Chen now anticipates that the biopharmaceutical company will earn ($0.37) per share for the quarter, down from […]
